Chemical Structure (Gemtesa 01)
Gemtesa Tablet, Film Coated
Product Images NDC 73336-075
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Gemtesa (NDC 73336-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sumitomo Pharma America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Gemtesa 02)
The given text appears to be a table of LS Mean (SE) Change from Baseline for treatment and placebo with GEMTESA 75 mg. The table shows the change in values at week 2, 4, 8, and 12 from the baseline. The values are present for both the treatment and placebo groups. This data could be useful for researchers and analysts who are studying the effects of GEMTESA 75 mg on the patients.*
Figure 2 (Gemtesa 03)
The text seems to be a table showing the LS means (with SE) change from baseline for a treatment and placebo group over 12 weeks. The treatment used is GEMTESA at a dosage of 75mg with 403 participants and a placebo group had 405 participants. The values seem to range from -2.254 to 0.50.*
Principal Display Panel (75 mg Tablet Bottle Label)
This is a description for a medicine called GEMTESA. The product comes in the form of tablets and the package contains 30 tablets with the NDC code 73336-075-30. The medication is only available with a prescription. Each tablet contains 75mg of the active ingredient vibegron. The recommended dosage is one tablet per day, which can be taken whole or crushed. The full prescribing information should be read before use. The package is child-resistant and should be kept out of the reach of children. The medicine should be stored at a temperature between 20°C and 25°C. Urovant Sciences, Inc. manufactures Gemtesa, and patient resources can be found by visiting gemtesa.com or calling 1-833-UROVANT.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
